664 related articles for article (PubMed ID: 15166036)
1. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
2. PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors.
Schmidt EK; Fichelson S; Feller SM
BMC Biol; 2004 May; 2():7. PubMed ID: 15149544
[TBL] [Abstract][Full Text] [Related]
3. Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors.
Lee AW; States DJ
Mol Cell Biol; 2000 Sep; 20(18):6779-98. PubMed ID: 10958675
[TBL] [Abstract][Full Text] [Related]
4. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
6. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
Wang W; Chen JX; Liao R; Deng Q; Zhou JJ; Huang S; Sun P
Mol Cell Biol; 2002 May; 22(10):3389-403. PubMed ID: 11971971
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways.
Sawafuji K; Miyakawa Y; Kizaki M; Ikeda Y
Am J Hematol; 2003 Jan; 72(1):67-9. PubMed ID: 12508271
[TBL] [Abstract][Full Text] [Related]
8. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
9. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
Myklebust JH; Blomhoff HK; Rusten LS; Stokke T; Smeland EB
Exp Hematol; 2002 Sep; 30(9):990-1000. PubMed ID: 12225790
[TBL] [Abstract][Full Text] [Related]
10. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.
Kadri Z; Petitfrère E; Boudot C; Freyssinier JM; Fichelson S; Mayeux P; Emonard H; Hornebeck W; Haye B; Billat C
Cell Growth Differ; 2000 Nov; 11(11):573-80. PubMed ID: 11095246
[TBL] [Abstract][Full Text] [Related]
12. Proliferation of IL-6-independent multiple myeloma does not require the activity of extracellular signal-regulated kinases (ERK1/2).
Zhang B; Fenton RG
J Cell Physiol; 2002 Oct; 193(1):42-54. PubMed ID: 12209879
[TBL] [Abstract][Full Text] [Related]
13. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
[TBL] [Abstract][Full Text] [Related]
15. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes.
Xiao L; Pimental DR; Amin JK; Singh K; Sawyer DB; Colucci WS
J Mol Cell Cardiol; 2001 Apr; 33(4):779-87. PubMed ID: 11273730
[TBL] [Abstract][Full Text] [Related]
16. Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways.
Peyssonnaux C; Provot S; Felder-Schmittbuhl MP; Calothy G; Eychène A
Mol Cell Biol; 2000 Oct; 20(19):7068-79. PubMed ID: 10982823
[TBL] [Abstract][Full Text] [Related]
17. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.
Morgan MA; Dolp O; Reuter CW
Blood; 2001 Mar; 97(6):1823-34. PubMed ID: 11238126
[TBL] [Abstract][Full Text] [Related]
18. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
Li XA; Bianchi C; Sellke FW
J Surg Res; 2001 Oct; 100(2):197-204. PubMed ID: 11592793
[TBL] [Abstract][Full Text] [Related]
19. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways.
Fukazawa H; Uehara Y
Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes.
Wang L; Gout I; Proud CG
J Biol Chem; 2001 Aug; 276(35):32670-7. PubMed ID: 11431469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]